ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,784,000 | -50.0% | 120,400 | -46.9% | 2.46% | -50.7% |
| Q2 2022 | $3,567,000 | -47.8% | 226,600 | -10.5% | 4.99% | -30.9% |
| Q1 2022 | $6,829,000 | -61.5% | 253,300 | -47.2% | 7.22% | -43.7% |
| Q4 2021 | $17,743,000 | -18.4% | 479,400 | +5.3% | 12.83% | +13.8% |
| Q3 2021 | $21,754,000 | +41.2% | 455,300 | 0.0% | 11.27% | +42.4% |
| Q2 2021 | $15,408,000 | – | 455,300 | – | 7.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |